Register Login

Werewolf Therapeutics Inc (HOWL)

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 164K shares of Werewolf Therapeutics, Inc. (at $0.64 each, total $106K) Filed: Jan 06, 2026 | ID: 000951

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 9:58 p.m.

    📋 Form 144 Filing: UBS Oncology Impact Fund, L.P.

    Company: Werewolf Therapeutics, Inc.

    Filing Date: 2026-01-06

    Relationship: Shareholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 164,126
    • Price per Share: $0.64
    • Total Value: $105,762.79
    • Planned Sale Date: 2026-01-06
    • Broker: Merrill Lynch
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-40366
    • Issuer Contact Phone: 6179520555
    • Issuer Address: 200 Talcott Avenue, 2nd Floor, Watertown, MA, 02472
    • Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 48540200.0
    • Number of Securities to be Sold: 1
    • Remarks: Please see attached for securities sold over the last 3 months
    • Signature: Kristen Laguerre

Search

News categories